Evidence map›Paper›PMID 25068783›Full record

ArticleMolecules (Basel, Switzerland)2014

Characterization and antitumor activity of a polysaccharide from Sarcodia ceylonensis.

Yijun Fan, Mengchuan Lin, Aoshuang Luo, Ze Chun, Aoxue Luo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Synergistic Effects ofAntioxidants (Basel, Switzerland) · 2023
    Article
  4. Isolation, Structural Characteristics Analysis of aMolecules (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Anti-tumor activity of a polysaccharide from blueberry.Molecules (Basel, Switzerland) · 2015
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yijun FanDepartment of Landscape Plants, Sichuan Agriculture University, Chengdu 611130, China.
Mengchuan LinDepartment of Landscape Plants, Sichuan Agriculture University, Chengdu 611130, China.
Aoshuang LuoChengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Ze ChunChengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Aoxue LuoDepartment of Landscape Plants, Sichuan Agriculture University, Chengdu 611130, China. aoxueluo@sicau.edu.cn.
Chengdu Institute of Biology · CNSichuan Agricultural University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A water-soluble polysaccharide from Sarcodia ceylonensis was obtained by using the method of water-extraction and ethanol-precipitation. The polysaccharide was further purified by chromatography on AB-8 and ADS-7 columns, yielding a pure polysaccharide termed SCP-60. The molecular weight (Mw) of SCP-60 was calculated to be 50.0 kDa, based on the calibration curve obtained with a series of Dextran T standards. The results of FT-IR indicated that the polysaccharide contains the α-configuration of sugar units. GC-MS analysis revealed that SCP-60 was mainly composed of galactose and glucose. NMR spectroscopy revealed SCP-60 had the backbone consisting of → 6)-α-Manp-(1 →, α-D-Glcp-(1 →, → 6)-α-D-Glcp-(1 → and → 6)-α-Galp-(1 →. In order to evaluate the antitumor activity in vivo of the polysaccharide, a sarcoma 180 model was used. The results showed SCP-60 had strong antitumor ability, meanwhile, SCP-60 at a high dose (100 mg/kg) could significantly increase the thymic and splenic indices of S180 mice, and strongly promote the secretion of IL-2, TNF-α and IFN-γ, increase the SOD activities and reduce the concentrations of MDA in blood. Therefore the polysaccharide SCP-60 should be explored as a novel potential antitumor drug.

Indexed as

AnimalsAntineoplastic AgentsBody WeightCell Line, TumorCell SurvivalCytokinesMalondialdehydeMicePlant ExudatesPolysaccharidesRhodophytaSuperoxide DismutaseTumor BurdenAntineoplastic AgentsCytokinesMalondialdehydePlant ExudatesPolysaccharidesSuperoxide Dismutase

Identifiers

PMID25068783
PMCPMC6271904
OpenAlexW1976944836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.